Keryx Seeks To Scrap Shareholder Stock-Drop Suit
Keryx Biopharmaceuticals Inc. argued Monday that it shouldn't have to face a shareholder class action over alleged problems with a drug supply chain that resulted in a decline in stock value,...To view the full article, register now.
Already a subscriber? Click here to view full article